Consolidated Statement of Changes in Stockholders’ Equity - USD ($)	Series A Preferred Stock	Series B Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Other Comprehensive Loss	Total
Balance at Dec. 31, 2017	$ 31	$ 8	$ 1,976	$ (19,007)	$ 14,424,831	$ (21,775,107)		$ (7,367,307)
Balance, shares at Dec. 31, 2017	31,581	8,063	1,976,034	(27,667)
Common stock issued to settle vendor liabilities			$ 1		3,374			3,375
Common stock issued to settle vendor liabilities, shares			938
Stock based compensation			$ 81		547,224			547,305
Stock based compensation, shares			81,849
Issuance of common stock and warrants in exchange for Series A and accrued dividend	$ (31)		$ 1,112		2,199,011			2,200,123
Issuance of common stock and warrants in exchange for Series A and accrued dividend, shares	(31,581)		1,112,488
Issuance of common stock and warrants in exchange for series B and accrued dividend		$ (8)	$ 231		468,953			469,184
Issuance of common stock and warrants in exchange for series B and accrued dividend, shares		(8,063)	230,842
Cash received for common stock and warrants			$ 557		2,786,905			2,787,462
Cash received for common stock and warrants, shares			557,492
Common stock and warrants issued upon conversion of notes payable			$ 2,256		11,938,507			11,940,763
Common stock and warrants issued upon conversion of notes payable, shares			2,256,448
Stock issuance cost			$ 210		(161,613)			161,403
Stock issuance cost, shares			210,000
Stock warrants issued with note payable					1,660,986			1,660,986
Issuance of common stock for prepaid services			$ 31		116,269			116,300
Issuance of common stock for prepaid services, shares			30,500
Common stock issued with note payable			$ 19		77,468			77,487
Common stock issued with note payable, shares			18,750
BCF issued with note payable				$ 38,413				38,413
Purchase of treasury stock				(33,334)				(33,334)
Inducement expense						(2,016,635)		(2,016,635)
Dividends						(739,782)		(739,782)
Net loss						(12,013,542)		(12,013,542)
Balance at Dec. 31, 2018			$ 6,475	$ (52,341)	34,100,327	(36,545,065)		(2,490,604)
Balance, shares at Dec. 31, 2018			6,475,340	(27,667)
Stock based compensation			$ 126		436,980			437,106
Stock based compensation, shares			125,227
Issuance of common stock and warrants in exchange for Series A and accrued dividend
Issuance of common stock and warrants in exchange for series B and accrued dividend
Cash received for common stock and warrants			$ 130		649,699			649,829
Cash received for common stock and warrants, shares			129,966
Tender offering			$ 2,100		(2,100)
Tender offering, shares			2,100,173
Common stock and warrants issued upon conversion of notes payable
Stock issuance cost					(178,146)			(178,146)
Stock warrants issued with note payable					427,692			427,692
Purchase of treasury stock and warrants				$ (314,833)	(271,658)			(586,491)
Purchase of treasury stock and warrants, shares				(132,183)
Shares issued for acquisition			$ 333		1,166,336			1,166,669
Shares issued for acquisition, shares			333,334
Common stock issued with note payable					427,692
BCF issued with note payable					4,444			4,444
Shares issued to settle vendor payable			$ 15		52,125			52,140
Shares issued to settle vendor payable, shares			14,897
Foreign currency translation adjustments							$ (5,995)	(5,995)
Net loss						(8,035,372)		(8,035,372)
Balance at Dec. 31, 2019			$ 9,178,937	$ (159,850)	$ 36,385,699	$ (44,580,437)	$ (5,995)	$ (8,558,728)
Balance, shares at Dec. 31, 2019			9,179	(367,174)